Coverage
-
March 17, 2023
A Maryland federal judge on Friday ordered a former chief financial officer of biotech company Osiris, Therapeutics Inc. who was accused by the U.S. Securities and Exchange Commission of securities fraud, to pay only $45,000 of the $224,000 he was found to be liable for.
9 other articles on this case.
View all »